Then, starting in 2012, the suit alleges that Teva and the other companies colluded to not only maintain their respective shares of the market, but raise prices on as many drugs as possible, with a particular focus on what it called "High Quality" competitors, whose products overlapped with its own.
Mike McClellan told a conference in Israel that the suit was an amended one and not new, while stressing it was civil and not criminal.
The lawsuit also names 15 senior executive defendants responsible for sales, marketing, pricing and operations.
Prosecutors said Teva Pharmaceuticals USA Inc had orchestrated to inflate drug prices - sometimes by more than 1,000% - and stifle competition for generic drugs.
In a press statement, Teva responded saying: "The allegations in this new complaint, and in the litigation more generally, are just that-allegations".
Teva's Tel Aviv-listed shares were down almost 11 percent in afternoon trading.
Teva's stock was the clear underperformer among the group as the Israel-based company was singled out by NYT for raising prices on almost 400 formulations of 112 generic drugs.
The suit contends that this resulted in "many billions of dollars of harm to the national economy over a period of several years". A coalition lead by CT, initially joined by 19 other states, filed the first suit in December 2016. "The size of the price increases varied, but a number of them were well over 1,000%", according to the court document.
The suit says that the defendants knew their conduct was unlawful and usually chose to communicate in person or by cell phone "in an attempt to avoid creating a written record of their illegal conduct".
'The company delivers high-quality medicines to patients around the world and is committed to complying with all applicable laws and regulations in doing so'.
The 500-page lawsuit accuses the generic drug industry, which mainly sells medicines that are off patent and should be less expensive, of a long history of discreet agreements to ensure that companies that are supposedly competitors each get a "fair share".
Mylan received similar backlash when it raised the price of a two-injection EpiPen set from $100 to $600.
Teva, which has denied any wrongdoing, said it would defend its actions.
Google Stadia Promises Cloud Gaming Revolution Across Devices
Google did not reveal when Stadia will launch or how much it will cost, although more details were promised during the summer. With the launch, Google is attempting a catch-all service that looks to the future of gaming as a digital cloud-based form.
Perfect without makeup
In an Instagram post, Alicia Keys and husband Swizz Beats posted a video about how they posed for a culture magazine together. Alicia Keys is still a superwoman slaying on red carpet relying only on good moisturizers, eyebrow gel and lipgloss.
Health- Get glowing skin with potatoes
Exfoliation : At times we feel like our skin is just too shiny, no matter how much makeup we apply. If you follow the below steps religiously, your skin texture will improve within a few weeks.